Histone lysine methyltransferases as anti-cancer targets for drug discovery
about
Targeting the epigenome in malignant pleural mesotheliomaG9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin.Development of a high-throughput fluorescence polarization assay for the discovery of EZH2-EED interaction inhibitors.E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidinHigh-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2
P2860
Histone lysine methyltransferases as anti-cancer targets for drug discovery
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Histone lysine methyltransferases as anti-cancer targets for drug discovery
@ast
Histone lysine methyltransferases as anti-cancer targets for drug discovery
@en
Histone lysine methyltransferases as anti-cancer targets for drug discovery
@nl
type
label
Histone lysine methyltransferases as anti-cancer targets for drug discovery
@ast
Histone lysine methyltransferases as anti-cancer targets for drug discovery
@en
Histone lysine methyltransferases as anti-cancer targets for drug discovery
@nl
prefLabel
Histone lysine methyltransferases as anti-cancer targets for drug discovery
@ast
Histone lysine methyltransferases as anti-cancer targets for drug discovery
@en
Histone lysine methyltransferases as anti-cancer targets for drug discovery
@nl
P2860
P3181
P356
P1476
Histone lysine methyltransferases as anti-cancer targets for drug discovery
@en
P2093
Ming-Wei Wang
P2860
P2888
P304
P3181
P356
10.1038/APS.2016.64
P407
P50
P577
2016-09-01T00:00:00Z
P6179
1002457183